Cargando…
Recalcitrant bullous pemphigoid responsive to dupilumab in an adolescent patient
Autores principales: | Zhou, Albert E., Shao, Kimberly, Ferenczi, Katalin, Adalsteinsson, Jonas A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579443/ https://www.ncbi.nlm.nih.gov/pubmed/36275873 http://dx.doi.org/10.1016/j.jdcr.2022.09.017 |
Ejemplares similares
-
Case Report: Combination of Omalizumab and Dupilumab for Recalcitrant Bullous Pemphigoid
por: Seyed Jafari, S. Morteza, et al.
Publicado: (2021) -
Effectiveness and safety of Dupilumab for the treatment at 104 weeks of recalcitrant bullous pemphigoid
por: Manzo Margiotta, Flavia, et al.
Publicado: (2023) -
Recalcitrant infantile bullous pemphigoid successfully treated with cyclosporine
por: Bar-Ilan, Efrat, et al.
Publicado: (2022) -
Cutaneous Cytomegalovirus Infection Presenting As Recalcitrant Bullous Pemphigoid Lesion
por: Baek, Gayun, et al.
Publicado: (2023) -
Successful Treatment of Psoriasis Combined with Bullous Pemphigoid with Dupilumab: A Case Report
por: Liu, Jing-Hua, et al.
Publicado: (2023)